Skip to content
  1. Home/
  2. Latest news/
  3. Health & wellness/
  4. Diabesity: The pandemic impacting populations around the globe
Diabesity: Global Epidemic Lede

Diabesity: The pandemic impacting populations around the globe

Obesity and diabetes rates are increasing so much that there’s a term for it: diabesity. Here’s what you should know about this worldwide health crisis.

They’re sobering statistics. Between 1980 and 2013, the number of overweight and obese people grew from 857 million to 2.1 billion globally. Today, over a quarter of those who are obese also have type 2 diabetes.
On their own, obesity and diabetes can lead to serious health complications—but when combined, “diabesity,” as experts are calling the simultaneous rise in both conditions, can really leave a detrimental mark on the health of people in nearly every corner of the globe.

As we mark World Diabetes Day on November 14, see how Johnson & Johnson is lending its support to help with the health crisis—and what steps you can take to be your best, healthy self.

Diabesity: A Global Pandemic Infographic-compressed.jpg

Here’s how you can learn more about the growing impact of diabetes and obesity around the world.

More from Johnson & Johnson

Could we be on our way to eliminating cancer for good?

What once seemed like an unattainable goal may soon be within our grasp. Learn how Johnson & Johnson is working toward its vision to create a world without cancer.

What are clinical trials?

Behind every innovative medicine, treatment and therapy is a clinical trial. To help you understand them better, here’s a closer look at how they work.

Meet two Johnson & Johnson nurse educators dedicated to teaching cancer care providers

Jennifer Huff and Jacqui Mellott are two of Johnson & Johnson’s oncology clinical educators—a team of 50 nurses who visit hospitals and infusion centers to help providers understand and stay up to date with treatments.